▶ 調査レポート

世界の肺がん診断市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Lung Cancer Diagnostics Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の肺がん診断市場規模・現状・予測(2021年-2027年) / Global Lung Cancer Diagnostics Market Size, Status and Forecast 2021-2027 / QYR2104Z3491資料のイメージです。• レポートコード:QYR2104Z3491
• 出版社/出版日:QYResearch / 2021年4月15日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、92ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、肺がん診断のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他)、用途別市場規模(産業用、医療、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・肺がん診断の市場動向
・企業の競争状況、市場シェア
・肺がん診断の種類別市場規模(イムノアッセイ、フローサイトメトリー、迅速検査、分子アッセイ、組織アレイ、循環腫瘍細胞、薬理診断、バイオマーカー、その他)
・肺がん診断の用途別市場規模(産業用、医療、その他)
・肺がん診断の北米市場規模2016-2027(アメリカ、カナダ)
・肺がん診断のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・肺がん診断のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・肺がん診断の中南米市場規模2016-2027(メキシコ、ブラジル)
・肺がん診断の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Roche Diagnostics、BioMérieux、Qiagen、Advpharma、AIT Austrian Institute of Technology、Courtagen Life Sciences、DiagnoCure、BioMark Diagnostics、Mayo Clinic、HalioDx SAS)
・結論

Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.
As people’s awareness of cancer increases and technology advances, as well as private and government support, these are some of the factors that are expected to drive market growth.

Market Analysis and Insights: Global Lung Cancer Diagnostics Market
The global Lung Cancer Diagnostics market size is projected to reach US$ 2783 million by 2026, from US$ 1883.5 million in 2019, at a CAGR of 5.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lung Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lung Cancer Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lung Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lung Cancer Diagnostics market.

Global Lung Cancer Diagnostics Scope and Market Size
Lung Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lung Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunoassays
Flow Cytometry
Rapid Tests
Molecular Assays
Tissue Arrays
Circulating Tumor Cells
Pharmacodiagnostics
Biomarkers
Other

Segment by Application
Industrial
Healthcare
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Roche Diagnostics
BioMérieux
Qiagen
Advpharma
AIT Austrian Institute of Technology
Courtagen Life Sciences
DiagnoCure
BioMark Diagnostics
Mayo Clinic

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunoassays
1.2.3 Flow Cytometry
1.2.4 Rapid Tests
1.2.5 Molecular Assays
1.2.6 Tissue Arrays
1.2.7 Circulating Tumor Cells
1.2.8 Pharmacodiagnostics
1.2.9 Biomarkers
1.2.10 Other
1.3 Market by Application
1.3.1 Global Lung Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Industrial
1.3.3 Healthcare
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lung Cancer Diagnostics Market Perspective (2016-2027)
2.2 Lung Cancer Diagnostics Growth Trends by Regions
2.2.1 Lung Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lung Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Lung Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Lung Cancer Diagnostics Industry Dynamic
2.3.1 Lung Cancer Diagnostics Market Trends
2.3.2 Lung Cancer Diagnostics Market Drivers
2.3.3 Lung Cancer Diagnostics Market Challenges
2.3.4 Lung Cancer Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Diagnostics Players by Revenue
3.1.1 Global Top Lung Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Lung Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Lung Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Diagnostics Revenue
3.4 Global Lung Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Lung Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnostics Revenue in 2020
3.5 Lung Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Lung Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Lung Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lung Cancer Diagnostics Breakdown Data by Type
4.1 Global Lung Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Lung Cancer Diagnostics Forecasted Market Size by Type (2022-2027)

5 Lung Cancer Diagnostics Breakdown Data by Application
5.1 Global Lung Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Lung Cancer Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lung Cancer Diagnostics Market Size (2016-2027)
6.2 North America Lung Cancer Diagnostics Market Size by Type
6.2.1 North America Lung Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Lung Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Lung Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America Lung Cancer Diagnostics Market Size by Application
6.3.1 North America Lung Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Lung Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Lung Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America Lung Cancer Diagnostics Market Size by Country
6.4.1 North America Lung Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Lung Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Lung Cancer Diagnostics Market Size (2016-2027)
7.2 Europe Lung Cancer Diagnostics Market Size by Type
7.2.1 Europe Lung Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Lung Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Lung Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe Lung Cancer Diagnostics Market Size by Application
7.3.1 Europe Lung Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Lung Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Lung Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe Lung Cancer Diagnostics Market Size by Country
7.4.1 Europe Lung Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Lung Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Lung Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Lung Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lung Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America Lung Cancer Diagnostics Market Size by Type
9.2.1 Latin America Lung Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Lung Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Lung Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Lung Cancer Diagnostics Market Size by Application
9.3.1 Latin America Lung Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Lung Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Lung Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Lung Cancer Diagnostics Market Size by Country
9.4.1 Latin America Lung Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Lung Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Lung Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Lung Cancer Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 BioMérieux
11.2.1 BioMérieux Company Details
11.2.2 BioMérieux Business Overview
11.2.3 BioMérieux Lung Cancer Diagnostics Introduction
11.2.4 BioMérieux Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.2.5 BioMérieux Recent Development
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen Lung Cancer Diagnostics Introduction
11.3.4 Qiagen Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.3.5 Qiagen Recent Development
11.4 Advpharma
11.4.1 Advpharma Company Details
11.4.2 Advpharma Business Overview
11.4.3 Advpharma Lung Cancer Diagnostics Introduction
11.4.4 Advpharma Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.4.5 Advpharma Recent Development
11.5 AIT Austrian Institute of Technology
11.5.1 AIT Austrian Institute of Technology Company Details
11.5.2 AIT Austrian Institute of Technology Business Overview
11.5.3 AIT Austrian Institute of Technology Lung Cancer Diagnostics Introduction
11.5.4 AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.5.5 AIT Austrian Institute of Technology Recent Development
11.6 Courtagen Life Sciences
11.6.1 Courtagen Life Sciences Company Details
11.6.2 Courtagen Life Sciences Business Overview
11.6.3 Courtagen Life Sciences Lung Cancer Diagnostics Introduction
11.6.4 Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.6.5 Courtagen Life Sciences Recent Development
11.7 DiagnoCure
11.7.1 DiagnoCure Company Details
11.7.2 DiagnoCure Business Overview
11.7.3 DiagnoCure Lung Cancer Diagnostics Introduction
11.7.4 DiagnoCure Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.7.5 DiagnoCure Recent Development
11.8 BioMark Diagnostics
11.8.1 BioMark Diagnostics Company Details
11.8.2 BioMark Diagnostics Business Overview
11.8.3 BioMark Diagnostics Lung Cancer Diagnostics Introduction
11.8.4 BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.8.5 BioMark Diagnostics Recent Development
11.9 Mayo Clinic
11.9.1 Mayo Clinic Company Details
11.9.2 Mayo Clinic Business Overview
11.9.3 Mayo Clinic Lung Cancer Diagnostics Introduction
11.9.4 Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.9.5 Mayo Clinic Recent Development
11.10 HalioDx SAS
11.10.1 HalioDx SAS Company Details
11.10.2 HalioDx SAS Business Overview
11.10.3 HalioDx SAS Lung Cancer Diagnostics Introduction
11.10.4 HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2016-2021)
11.10.5 HalioDx SAS Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lung Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunoassays
Table 3. Key Players of Flow Cytometry
Table 4. Key Players of Rapid Tests
Table 5. Key Players of Molecular Assays
Table 6. Key Players of Tissue Arrays
Table 7. Key Players of Circulating Tumor Cells
Table 8. Key Players of Pharmacodiagnostics
Table 9. Key Players of Biomarkers
Table 10. Key Players of Other
Table 11. Global Lung Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Lung Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 13. Global Lung Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 14. Global Lung Cancer Diagnostics Market Share by Regions (2016-2021)
Table 15. Global Lung Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 16. Global Lung Cancer Diagnostics Market Share by Regions (2022-2027)
Table 17. Lung Cancer Diagnostics Market Trends
Table 18. Lung Cancer Diagnostics Market Drivers
Table 19. Lung Cancer Diagnostics Market Challenges
Table 20. Lung Cancer Diagnostics Market Restraints
Table 21. Global Lung Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 22. Global Lung Cancer Diagnostics Market Share by Players (2016-2021)
Table 23. Global Top Lung Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostics as of 2020)
Table 24. Ranking of Global Top Lung Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 25. Global 5 Largest Players Market Share by Lung Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Lung Cancer Diagnostics Product Solution and Service
Table 28. Date of Enter into Lung Cancer Diagnostics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 31. Global Lung Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 32. Global Lung Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 33. Global Lung Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 34. Global Lung Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 35. Global Lung Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 36. Global Lung Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 37. Global Lung Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 38. North America Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 39. North America Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 40. North America Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 41. North America Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 42. North America Lung Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 43. North America Lung Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Europe Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 45. Europe Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Europe Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 47. Europe Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Europe Lung Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 49. Europe Lung Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 51. Asia-Pacific Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 53. Asia-Pacific Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 55. Asia-Pacific Lung Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 56. Latin America Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 57. Latin America Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Latin America Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 59. Latin America Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Latin America Lung Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Latin America Lung Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 63. Middle East & Africa Lung Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 65. Middle East & Africa Lung Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 66. Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 67. Middle East & Africa Lung Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 68. Roche Diagnostics Company Details
Table 69. Roche Diagnostics Business Overview
Table 70. Roche Diagnostics Lung Cancer Diagnostics Product
Table 71. Roche Diagnostics Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Roche Diagnostics Recent Development
Table 73. BioMérieux Company Details
Table 74. BioMérieux Business Overview
Table 75. BioMérieux Lung Cancer Diagnostics Product
Table 76. BioMérieux Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 77. BioMérieux Recent Development
Table 78. Qiagen Company Details
Table 79. Qiagen Business Overview
Table 80. Qiagen Lung Cancer Diagnostics Product
Table 81. Qiagen Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Qiagen Recent Development
Table 83. Advpharma Company Details
Table 84. Advpharma Business Overview
Table 85. Advpharma Lung Cancer Diagnostics Product
Table 86. Advpharma Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Advpharma Recent Development
Table 88. AIT Austrian Institute of Technology Company Details
Table 89. AIT Austrian Institute of Technology Business Overview
Table 90. AIT Austrian Institute of Technology Lung Cancer Diagnostics Product
Table 91. AIT Austrian Institute of Technology Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 92. AIT Austrian Institute of Technology Recent Development
Table 93. Courtagen Life Sciences Company Details
Table 94. Courtagen Life Sciences Business Overview
Table 95. Courtagen Life Sciences Lung Cancer Diagnostics Product
Table 96. Courtagen Life Sciences Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Courtagen Life Sciences Recent Development
Table 98. DiagnoCure Company Details
Table 99. DiagnoCure Business Overview
Table 100. DiagnoCure Lung Cancer Diagnostics Product
Table 101. DiagnoCure Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 102. DiagnoCure Recent Development
Table 103. BioMark Diagnostics Company Details
Table 104. BioMark Diagnostics Business Overview
Table 105. BioMark Diagnostics Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 106. BioMark Diagnostics Recent Development
Table 107. Mayo Clinic Company Details
Table 108. Mayo Clinic Business Overview
Table 109. Mayo Clinic Lung Cancer Diagnostics Product
Table 110. Mayo Clinic Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 111. Mayo Clinic Recent Development
Table 112. HalioDx SAS Company Details
Table 113. HalioDx SAS Business Overview
Table 114. HalioDx SAS Lung Cancer Diagnostics Product
Table 115. HalioDx SAS Revenue in Lung Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 116. HalioDx SAS Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Immunoassays Features
Figure 3. Flow Cytometry Features
Figure 4. Rapid Tests Features
Figure 5. Molecular Assays Features
Figure 6. Tissue Arrays Features
Figure 7. Circulating Tumor Cells Features
Figure 8. Pharmacodiagnostics Features
Figure 9. Biomarkers Features
Figure 10. Other Features
Figure 11. Global Lung Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 12. Industrial Case Studies
Figure 13. Healthcare Case Studies
Figure 14. Other Case Studies
Figure 15. Lung Cancer Diagnostics Report Years Considered
Figure 16. Global Lung Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Lung Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Lung Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 19. Global Lung Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 20. Global Lung Cancer Diagnostics Market Share by Players in 2020
Figure 21. Global Top Lung Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnostics as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Lung Cancer Diagnostics Revenue in 2020
Figure 23. Global Lung Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 24. Global Lung Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 25. North America Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Lung Cancer Diagnostics Market Share by Type (2016-2027)
Figure 27. North America Lung Cancer Diagnostics Market Share by Application (2016-2027)
Figure 28. North America Lung Cancer Diagnostics Market Share by Country (2016-2027)
Figure 29. United States Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Lung Cancer Diagnostics Market Share by Type (2016-2027)
Figure 33. Europe Lung Cancer Diagnostics Market Share by Application (2016-2027)
Figure 34. Europe Lung Cancer Diagnostics Market Share by Country (2016-2027)
Figure 35. Germany Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Lung Cancer Diagnostics Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Lung Cancer Diagnostics Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Lung Cancer Diagnostics Market Share by Region (2016-2027)
Figure 45. China Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Lung Cancer Diagnostics Market Share by Type (2016-2027)
Figure 53. Latin America Lung Cancer Diagnostics Market Share by Application (2016-2027)
Figure 54. Latin America Lung Cancer Diagnostics Market Share by Country (2016-2027)
Figure 55. Mexico Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Lung Cancer Diagnostics Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Lung Cancer Diagnostics Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Lung Cancer Diagnostics Market Share by Country (2016-2027)
Figure 61. Turkey Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Lung Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Roche Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 65. BioMérieux Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 66. Qiagen Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 67. Advpharma Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 68. AIT Austrian Institute of Technology Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 69. Courtagen Life Sciences Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 70. DiagnoCure Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 71. BioMark Diagnostics Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 72. Mayo Clinic Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 73. HalioDx SAS Revenue Growth Rate in Lung Cancer Diagnostics Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed